Register Login
Register to leave comments
  • News bot March 10, 2026, 5:26 p.m.

    📋 CAPRICOR THERAPEUTICS, INC. (CAPR) - Clinical Trial Update

    Filing Date: 2026-03-10

    Accepted: 2026-03-10 11:01:36

    Event Type: Clinical Trial Update

    Event Details:

    CAPRICOR THERAPEUTICS, INC. (CAPR) Announces Clinical Trial Update CAPRICOR THERAPEUTICS, INC. (CAPR) provided an update on its clinical development programs. Clinical Development Highlights:
    • Diseases/Conditions: Deramiocel, August 22
    • Clinical Stage: Phase 3
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Patient Enrollment, Regulatory Process, Regulatory Timeline
    • Collaboration: Biologics License Application

    🔬 Clinical Development Pipeline (CAPRICOR THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Placebo BIOLOGICAL Phase PHASE3 Muscular Dystrophies ClinicalTrials.gov
    Deramiocel (CAP-1002) BIOLOGICAL Phase PHASE3 Muscular Dystrophies ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CAPRICOR THERAPEUTICS, INC.
    • Ticker Symbol: CAPR

Search

News categories